MedTrace Logo

Project 500 CHILD Study

NCT03225534 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2017-09-25

No results posted yet for this study

Summary

This proposal relates to the testing of several specific hypotheses in a subset of 500 participants in the Canadian Healthy Infant Longitudinal Development (CHILD) Study. These 500 now have complete data from the time of recruitment (in pregnancy) to age 1 year. The primary purpose of this proposal is to identify risk factors for early allergic outcomes and biomarkers that may predict future disease. These 500 infants will provide critical preliminary data, not only related to early outcomes, but also to inform analytical plans for the full CHILD cohort.

Conditions

  • Asthma in Children
  • Allergy in Children
  • Environmental Exposure
  • Genetic Predisposition

Sponsors & Collaborators

  • Allergy, Genes and Environment Network (AllerGen) NCE

    collaborator UNKNOWN

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • St. Joseph's Healthcare Hamilton

    collaborator OTHER

  • University of Toronto

    collaborator OTHER

  • University of Manitoba

    collaborator OTHER

  • University of Alberta

    collaborator OTHER

  • University of British Columbia

    collaborator OTHER

  • McMaster University

    lead OTHER

Principal Investigators

  • Padmaja Subbarao, MD · University of Toronto

Eligibility

Min Age
1 Day
Max Age
18 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2012-10-31
Completion
2018-03-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03225534 on ClinicalTrials.gov